NEWPORT, RI -- October 18, 2021 -- The Hope Funds for Cancer Research, dedicated to advancing research for the most difficult-to-treat cancers, has announced that Hope Funds Fellow Nitin Shirole, Ph.D. is the recipient of the Hope Funds Sakonnet Fellowship.
Dr. Shirole is in the Laboratory of Dr. William G. Kaelin, Jr. at Howard Hughes Medical Institute/Dana-Farber Cancer Institute. Dr. Kaelin is a 2019 Hope Funds Award of Excellence recipient for Basic Science and received the Nobel Prize in Medicine or Physiology that same year. Dr. Shirole received his B.Sc. in Biotechnology from Nagpur University, M.S. in Cell and Molecular Biology from The University of Alabama, and Ph.D. in Genetics/Cancer Biology from Stony Brook University. The aim of his research is to understand why kidney cancer cells are dependent on paralogous protein function.
"Hope Funds is deeply grateful to the Thomas A Rodgers Jr Family Foundation for supporting this postdoctoral fellowship," said Leah Rush Cann, Chair, Hope Funds Executive Committee.
"Postdoctoral studies, research and mentorship are important steps beyond the doctoral degrees our Hope Funds Fellows have achieved," said Mrs. Cann "These aspects help augment the potential for excellence in research of Fellows, such as Dr. Shirole, and lead to important work.”
About the Hope Funds Fellowships
The Hope Funds for Cancer Research supports research for highly innovative projects that challenge the traditional paradigms associated with understanding the causes, mechanisms, progression, disease markers, or risk factors of the most difficult-to-treat cancers. Hope Funds believes it is important to emphasize creative approaches to research and award grants to young scientists based on the following criteria: project innovation and originality; the significance and direct relevance of the research proposal; the project's approach and conceptual framework; the researcher's qualifications and those of his or her mentors; and the quality of the researcher's overall working environment.
About Hope Funds for Cancer Research
Hope Funds for Cancer Research was formed in 2006 to establish a funding vehicle that would take a rational scientific, medical, and investment approach to making grants for the most innovative and promising research efforts to address the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, renal and ovarian cancers, as well as rare leukemias, lymphomas and MDS. These cancers are insidiously aggressive illnesses that kill most of their victims within months, even with aggressive chemotherapy. The Trustees of the Hope Funds for Cancer Research believe that funding young, innovative researchers will lead to breakthroughs in these areas and increase life expectancy for those with these types of cancers. The Hope Funds for Cancer Research is a 509 (a)(1) charity under 501(c)(3) of the Internal Revenue Service's code.
For additional information about the organization, please visit www.hope-funds.org or call (401) 847-3286.
Hope Funds for Cancer Research: Advancing innovative research in understudied cancers
Hope Funds for Cancer Research is an independent and unaffiliated non-profit organization
10/18/2021- 13
